BioNTech
Information

BioNTech

ISIN
US09075V1026
Ticker
BNTX
ISIN
US09075V1026
Ticker
BNTX
New Post
$133.77
- $1.57
-1.16%

Information

large cap stock
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
3,082
Industries
Biotechnology & Drugs
Sector
Health Care

Community

Financials

52W span
$117.08
$369.68
Market Cap
$32.47B
Free Float
214.95M
Shares outstanding
242.52M

Analyst Ratings

Target Price
$225.82
This security is covered by 17 analysts
Buy
7
Hold
10
Sell
0

Dividends

Activities

Trending